Edgewise Therapeutics, Inc. Common Stock (EWTX) is a publicly traded Healthcare sector company. As of May 21, 2026, EWTX trades at $32.78 with a market cap of $3.41B and a P/E ratio of -20.05. EWTX moved +4.36% today. Year to date, EWTX is +39.24%; over the trailing twelve months it is +120.71%. Its 52-week range spans $10.60 to $39.96. Analyst consensus is strong buy with an average price target of $41.70. Rallies surfaces EWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Edgewise Grants 72,000 Options at $32.46 Strike to Four New Hires: On March 31, 2026, Edgewise Therapeutics granted inducement stock options for 72,000 common shares to four new non-executive employees under its 2024 Inducement Equity Incentive Plan. Each option has a $32.46 exercise price matching the grant-date close and vests 25% after one year then monthly over 36 months.
| Metric | Value |
|---|---|
| Price | $32.78 |
| Market Cap | $3.41B |
| P/E Ratio | -20.05 |
| EPS | $-1.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.96 |
| 52-Week Low | $10.60 |
| Volume | 627.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-167.79M |
| Gross Margin | 0.00% |
10 analysts cover EWTX: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.70.